| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $1.0M | -32.2% |
| Operating Income | -$1.0M | -107.2% |
| Income Tax | $0 | — |
| Net Income | -$1.7M | -106.9% |
| EPS (Basic) | -$0.02 | -100.0% |
| EPS (Diluted) | -$0.02 | -100.0% |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Current Assets | $50K | -12.7% |
| Total Assets | $50K | -91.5% |
| Current Liabilities | $7.0M | +18.3% |
| Stockholders' Equity | -$7.0M | -30.4% |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$347K | +71.4% |
| Investing Cash Flow | $70K | -93.0% |
| Financing Cash Flow | $294K | +62.9% |